Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-07 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-06 |